Your browser doesn't support javascript.
loading
Hematopoiesis under telomere attrition at the single-cell resolution.
Thongon, Natthakan; Ma, Feiyang; Santoni, Andrea; Marchesini, Matteo; Fiorini, Elena; Rose, Ashley; Adema, Vera; Ganan-Gomez, Irene; Groarke, Emma M; Gutierrez-Rodrigues, Fernanda; Chen, Shuaitong; Lockyer, Pamela; Schneider, Sarah; Bueso-Ramos, Carlos; Montalban-Bravo, Guillermo; Class, Caleb A; Soltysiak, Kelly A; Pellegrini, Matteo; Sahin, Ergun; Bertuch, Alison A; DiNardo, Courtney D; Garcia-Manero, Guillermo; Young, Neal S; Dwyer, Karen; Colla, Simona.
Afiliação
  • Thongon N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ma F; Division of Rheumatology, Department of Internal Medicine, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
  • Santoni A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Marchesini M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Fiorini E; IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy.
  • Rose A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Adema V; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ganan-Gomez I; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Groarke EM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gutierrez-Rodrigues F; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Chen S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
  • Lockyer P; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Schneider S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bueso-Ramos C; Department of Stem Cell Transplantation and Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Montalban-Bravo G; Department of Hematopathology, The University of Texas MD Cancer Center, Houston, TX, USA.
  • Class CA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Soltysiak KA; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pellegrini M; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Butler University, Indianapolis, IN, USA.
  • Sahin E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Bertuch AA; Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA, USA.
  • DiNardo CD; Huffington Center On Aging, Baylor College of Medicine, Houston, TX, USA.
  • Garcia-Manero G; Department of Pediatrics and Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, USA.
  • Young NS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Dwyer K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Colla S; Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA.
Nat Commun ; 12(1): 6850, 2021 11 25.
Article em En | MEDLINE | ID: mdl-34824242
ABSTRACT
The molecular mechanisms that drive hematopoietic stem cell functional decline under conditions of telomere shortening are not completely understood. In light of recent advances in single-cell technologies, we sought to redefine the transcriptional and epigenetic landscape of mouse and human hematopoietic stem cells under telomere attrition, as induced by pathogenic germline variants in telomerase complex genes. Here, we show that telomere attrition maintains hematopoietic stem cells under persistent metabolic activation and differentiation towards the megakaryocytic lineage through the cell-intrinsic upregulation of the innate immune signaling response, which directly compromises hematopoietic stem cells' self-renewal capabilities and eventually leads to their exhaustion. Mechanistically, we demonstrate that targeting members of the Ifi20x/IFI16 family of cytosolic DNA sensors using the oligodeoxynucleotide A151, which comprises four repeats of the TTAGGG motif of the telomeric DNA, overcomes interferon signaling activation in telomere-dysfunctional hematopoietic stem cells and these cells' skewed differentiation towards the megakaryocytic lineage. This study challenges the historical hypothesis that telomere attrition limits the proliferative potential of hematopoietic stem cells by inducing apoptosis, autophagy, or senescence, and suggests that targeting IFI16 signaling axis might prevent hematopoietic stem cell functional decline in conditions affecting telomere maintenance.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encurtamento do Telômero / Hematopoese Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Encurtamento do Telômero / Hematopoese Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article